Diclofenac-potassium
Diclofenac-potassium seemed to be as        well tolerated as placebo, with fewer adverse events reported than after       sumatriptan treatment and with more patients assessing the overall tolerability       of diclofenac-potassium better than that of sumatriptan.
 @SUBJECT$  seemed to be as        well tolerated  @PREDICAT$   @OBJECT$ , with fewer adverse events reported than after       sumatriptan treatment and with more patients assessing the overall tolerability       of diclofenac-potassium better than that of sumatriptan.